Clinical trial Recruiting at 1 site Interventional Ages 3 to 6

EMDR therapy for young children with trauma and anxiety

Official title: Is Eye-Movement Desensitization and Reprocessing (EMDR) Therapy Effective in Children Aged 3 to 6 Years With Trauma-related Disorders or Stressors and Anxiety? A Double-blinded Randomized Controlled Trial.

Run by Fondation Lenval · NCT05419934 · Data updated 2026-11-12

This study is testing if EMDR therapy can help young children aged 3 to 6 who are dealing with trauma and anxiety feel better.

Quick facts

Study typeInterventional
Ages3 Years to 6 Years
SexAll
Enrollment60 (estimated)
SponsorFondation Lenval
Academic / other
Locations1 site (Nice)
StatusRecruiting
StartedSeptember 27, 2022
Main results expectedOctober 15, 2024
Study endsDecember 2025
Registry record updatedApril 1, 2025
Trial IDNCT05419934 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 3 to 6 with diagnosed trauma-related or anxiety disorders.

Probably not a fit

Patients with neurodevelopmental disorders or those currently on psychotropic medications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project investigates the effectiveness of Eye-Movement Desensitization and Reprocessing (EMDR) therapy in children aged 3 to 6 years who are experiencing trauma-related disorders and anxiety. The study will enroll 60 children, randomly assigning them to either an EMDR therapy group or a control therapy group. The research will be conducted in four phases: pre-treatment evaluation, treatment administration over 6 to 10 weeks, post-treatment reassessment, and continuation of care for those in the control group. The aim is to determine if EMDR is effective and how cognitive functioning impacts therapy outcomes in this young population.

Why it matters

Potential benefit: If successful, this study could provide effective therapeutic options for young children suffering from trauma and anxiety disorders.

How similar studies have gone: While EMDR has shown promise in older populations, this specific application in very young children is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Child aged 3 to 6 at the time of inclusion;
* Established diagnosis of one or more disorders related to a trauma or a stress factor, and/or an anxiety disorder, assessed by the Diagnostic Infant and Preschool Assessment (DIPA) diagnostic tool
* Typical language

Exclusion Criteria:

* Child taking a psychotropic treatment
* Suicidal intentions or ideation of the main caregivers, or of the child, and self-harming behavior;
* Parent(s) or care figure(s) with a substance use disorder;
* Presence or diagnosis of specific pathological conditions in the child (neurodevelopmental disorders based on Diagnostic and Statistical Manual of Mental Disorders (DSM V) criteria, brain trauma, or neurological pathology);
* Participation of the child in another biomedical research on the psychic care of disorders related to trauma or stress and anxiety factors

Where it's running

  • Hôpitaux Pédiatriques de Nice CHU-Lenval
    Nice, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.